MABTAS INJ-500mg
MABTAS Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis
| Manufacturer /Marketed by | Intas |
|---|---|
| Contains / Molecules | RITUXIMAB |
| Strength | 500mg |
| Packing | 50ml in 1 vial |
| International Name | MABTAS INJ-500mg |
